Definigen
Stem cell life science products and services
Definigen has raised €2.8M across 1 funding round from 2 investors, most recently a Series A round in Jun 2014. Based in Cambridge, UK; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.8M
€2,792,680
Funding rounds
1
Investors
2
distinct backers
Active since
2014-06
latest 2014-06
Funding by year
EUR raised per yearDefinigen — funding by year — interactive chart.
Data table
| Definigen — funding by year | |
|---|---|
| 2014 | €2.8M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-06-01 | Series A | €2.8M | 24Haymarket,London Business Angels (Angel Capital Group) | View deal → |
Investors
224HaymarketLondon Business Angels (Angel Capital Group)
Similar companies
same sector or countryGlobal coverage: FundingData